TumVol Cancer Research Results

TumVol, Tumor Volume: Click to Expand ⟱
Source:
Type:
Tumor Volume
Scientific Papers found: Click to Expand⟱
6463- 1,8-Cin,    Antitumor effect of 1, 8-cineole against colon cancer
- vitro+vivo, Colon, HCT116
TumCP↓, Apoptosis↑, survivin↓, Akt↓, p38↑, cl‑PARP↑, cl‑Casp3↑, TumVol↓,
5263- 3BP,  CET,    3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis
- in-vitro, CRC, DLD1 - NA, NA, HCT116
Synergy↑, Ferroptosis↓, TumAuto↑, Apoptosis↑, FOXO3↑, AMPKα↑, p‑Beclin-1/ATG6↑, HK2↓, ATP↓, ROS↑, Dose↝, TumVol↓, TumW↓, xCT/SLC7A11↑, GSH↓, eff↓, MDA↑,
9259- Acai, EO,    Antitumor Effect of Açaí (Euterpe oleracea Mart.) Seed Extract in LNCaP Cells and in the Solid Ehrlich Carcinoma Model
- vitro+vivo, Pca, LNCaP
Ingr↝, eff↝, Dose↝, TumVol↓, necrosis↑, IL6↓, IFN-γ↓,
5975- AgNPs,  PDT,  CDT,  RF,    Recent Advances in the Application of Silver Nanoparticles for Enhancing Phototherapy Outcomes
- Review, Var, NA - Review, BPH, NA
ROS↑, EPR↓, Synergy↑, Bacteria↓, eff↑, eff↑, TumVol↓,
4394- AgNPs,    Silver nanoparticles provoke apoptosis of Dalton's ascites lymphoma in vivo by mitochondria dependent and independent pathways
- in-vivo, lymphoma, NA
OS↑, TumVol↓, Weight↑, AntiTum↑, Apoptosis↑, mtDam↑,
4431- AgNPs,  doxoR,    Oxidative Stress-Induced Silver Nano-Carriers for Chemotherapy
- in-vitro, BC, 4T1 - in-vivo, BC, 4T1 - in-vitro, Nor, 3T3
AntiCan↑, ROS↑, TumVol↓, EPR↑, selectivity↑, ChemoSen↑,
4361- AgNPs,  GoldNP,    Biocompatible silver, gold and silver/gold alloy nanoparticles for enhanced cancer therapy: in vitro and in vivo perspectives
- in-vivo, Liver, HepG2
TumCD↑, TumVol↓, *toxicity↝, hepatoP↑,
4363- AgNPs,    Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma
- in-vivo, fibroS, NA
TumVol↓, TNF-α↓, IL6↓, IL1β↓, *toxicity↝, TumCG↓, selectivity↑, selectivity↑, Weight↑, ROS↑, NO↑,
312- AgNPs,  wortm,    Inhibition of autophagy enhances the anticancer activity of silver nanoparticles
- vitro+vivo, Cerv, HeLa
APA↑, p62↓, PIK3CA↑, TumVol↓, TumAuto↑, eff↑,
362- AgNPs,    Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer
- vitro+vivo, SCC, SCC9
DNAdam↑, TumVol↓,
390- AgNPs,    Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line
- in-vitro, BC, MDA-MB-231 - in-vivo, BC, NA
ROS↑, TumVol↓,
378- AgNPs,    Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer
- ex-vivo, BC, 4T1
TumVol↓, TumMeta↓, Ki-67↓,
9223- AITC,    Allyl isothiocyanate inhibits invasion and angiogenesis in breast cancer via EGFR-mediated JAK-1/STAT-3 signaling pathway
- in-vivo, BC, NA
COL1↓, angioG↓, TumCI↓, STAT3↓, JAK1↓, Dose↝, TumNum↓, TumVol↓,
9224- AITC,    Allyl Isothiocyanate (AITC) Induces Apoptotic Cell Death In Vitro and Exhibits Anti-Tumor Activity in a Human Glioblastoma GBM8401/ luc2 Model
- vitro+vivo, GBM, NA
tumCV↓, Apoptosis↑, Bcl-2↓, Mcl-1↓, BAX↑, Casp3↑, Casp8↑, Casp9↑, Dose↝, TumCG↓, TumVol↓, TumW↓, toxicity↓, XIAP↓, MMP9↓, VEGF↓,
5342- Ajoene,    The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis
- in-vivo, BCC, NA
TumVol↓, Bcl-2↓, Apoptosis↑,
546- AL,    Effects of garlic intake on cancer: a systematic review of randomized clinical trials and cohort studies
- Review, Var, NA
Risk↓, TumVol↓,
1069- AL,    Allicin promotes autophagy and ferroptosis in esophageal squamous cell carcinoma by activating AMPK/mTOR signaling
- vitro+vivo, ESCC, TE1 - vitro+vivo, ESCC, KYSE-510 - in-vitro, Nor, Het-1A
TumCP↓, LC3‑Ⅱ/LC3‑Ⅰ↑, p62↓, p‑AMPK↑, mTOR↓, TumAuto↑, NCOA4↑, MDA↑, Iron↑, TumW↓, TumVol↓, ATG5↑, ATG7↑, TfR1/CD71↓, FTH1↓, ROS↑, Iron↑, Ferroptosis↑, *toxicity↓,
271- ALA,  VitC,  LDN,    The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol
- Case Report, RCC, NA
OS↑, Weight↑, TumVol↓,
1546- Api,    Apigenin in Cancer Prevention and Therapy: A Systematic Review and Meta-Analysis of Animal Models
- Review, Var, NA
TumVol↓, TumW↓, AntiCan↑, Apoptosis↑, TumCCA↑,
1553- Api,    Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy
- Review, Var, NA
Dose∅, TumVol↓, Dose∅, COX2/PTGS2↓, Hif1a↓, TumCCA↑, P53↑, P21↑, Casp3↑, DNAdam↑, TumAuto↝,
1564- Api,    Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
- in-vitro, Pca, 22Rv1 - in-vivo, NA, NA
MDM2↓, NF-kB↓, p65↓, P21↑, ROS↑, GSH↓, MMP↓, Cyt‑c↑, Apoptosis↑, P53↑, eff↓, Bcl-xL↓, Bcl-2↓, BAX↑, Casp↑, TumCG↓, TumVol↓, TumW↓,
177- Api,    Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression
- in-vitro, BC, MDA-MB-231
Cyc↓, CycB/CCNB1↓, CDK1↓, P21↑, PCNA↝, HDAC↓, TumCP↓, TumCCA↑, ac‑H3↑, TumW↓, TumVol↓,
2319- Api,    Apigenin sensitizes radiotherapy of mouse subcutaneous glioma through attenuations of cell stemness and DNA damage repair by inhibiting NF-κB/HIF-1α-mediated glycolysis
- in-vitro, GBM, NA
Glycolysis↓, NF-kB↓, p65↓, Hif1a↓, GLUT1↓, GLUT3↓, PKM2↓, RadioS↑, TumVol↓, TumW↓,
3391- ART/DHA,    Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
- Review, Var, NA
TumCP↓, TumMeta↓, angioG↓, TumVol↓, BioAv↓, Half-Life↓, BioAv↑, eff↑, eff↓, ROS↑, selectivity↑, TumCCA↑, survivin↓, BAX↑, Casp3↓, Casp8↑, Casp9↑, CDC25↓, CycB/CCNB1↓, NF-kB↓, cycD1/CCND1↓, cycE/CCNE↓, E2Fs↓, P21↑, p27/CDKN1B↑, ADP:ATP↑, MDM2↓, VEGF↓, IL8↓, COX2/PTGS2↓, MMP9↓, ER Stress↓, cMyc↓, GRP78/BiP↑, DNAdam↑, AP-1↓, MMP2↓, PKCδ↓, Raf↓, ERK↓, JNK↓, PCNA↓, CDK2↓, CDK4↓, TOP2↓, uPA↓, MMP7↓, TIMP2↑, Cdc42↑, E-cadherin↑,
1179- Ash,    Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity
- in-vitro, CRC, HCT116 - in-vivo, NA, NA
TumCP↓, TumCMig↓, STAT3↓, TumVol↓, TumW↓,
1177- Ash,    Withaferin A downregulates COX-2/NF-κB signaling and modulates MMP-2/9 in experimental endometriosis
- in-vivo, EC, NA
TumVol↓, MMP2↓, MMP9↓, NF-kB↓, COX2/PTGS2↓, NO↓, IL1β↓, IL6↓,
1176- Ash,    Metabolic Alterations in Mammary Cancer Prevention by Withaferin A in a Clinically Relevant Mouse Model
- in-vivo, Var, NA
TumVol↓, Apoptosis↑, Glycolysis↓, PKM2↓, PGK1↓, ALDOAiso2↓,
5499- Ba,    Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo
- vitro+vivo, Lung, H460 - vitro+vivo, Lung, A549
TumCP↓, Apoptosis↑, F-actin↓, TumVol↓, OS↑, 12LOX↓, VEGF↓, angioG↓,
2599- Ba,    Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231 - in-vivo, NA, NA
TumCP↓, Apoptosis↑, p‑Akt↓, p‑mTOR↓, NF-kB↓, p‑IKKα↓, IKKα↑, PI3K↓, MMP↓, TumAuto↑, TumVol↓, TumW↓,
5539- BBM,    Berbamine suppresses cell viability and induces apoptosis in colorectal cancer via activating p53-dependent apoptotic signaling pathway
- vitro+vivo, CRC, SW480
tumCV↓, TumCCA↑, MMP↓, P53↑, Casp3↑, Casp9↑, BAX↑, PARP↑, Bcl-2↓, TumVol↑,
5551- BBM,    Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis
- vitro+vivo, Bladder, NA
tumCV↓, TumCP↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK2↓, EMT↓, TumMeta↓, p65↓, p‑p65↓, IKKα↓, NF-kB↑, ROS↑, NRF2↓, HO-1↓, SOD2↓, GPx1↓, Bax:Bcl2↑, TumVol↓,
940- BBR,    Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression
- vitro+vivo, PC, PANC1 - in-vivo, PC, MIA PaCa-2
LDHA↓, lactateProd↓, AMPKα↓, TumVol↓, Ki-67↓,
5176- BBR,    Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice
- vitro+vivo, CRC, HCT116 - in-vitro, CRC, SW480 - in-vitro, CRC, LoVo
TumVol↓, Ki-67↓, COX2/PTGS2↓, AMPK↑, mTOR↓, NF-kB↓, cycD1/CCND1↓, survivin↓, P53↑, cl‑Casp3↑, TumCP↓, Inflam↓, COX2/PTGS2↓, ACC↑,
6518- BCP,    beta-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models
- vitro+vivo, CRC, HCT116
angioG↓, VEGF↓, TumVol↓, HSP60/HSPD1↓, HTRA↓, survivin↓, XIAP↓, P21↑, TumCP↓, TumCMig↓, TumCG↓, Dose↝,
6496- BCP,    β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models
- vitro+vivo, CRC, HCT116 - in-vitro, Nor, HUVECs
angioG↓, VEGF↓, TumVol↓, Apoptosis↑, HSP60/HSPD1↓, HTRA↓, survivin↓, XIAP↓, P21↑, *toxicity↓, *neuroP↑, *ROS↓, *COX2/PTGS2↓, *Inflam↓, *cardioP↑, AntiCan↑, ChemoSen↑, ROS↑, MMP↑, Bax:Bcl2↑, TumCG↓,
2717- BetA,    Betulinic Acid Induces ROS-Dependent Apoptosis and S-Phase Arrest by Inhibiting the NF-κB Pathway in Human Multiple Myeloma
- in-vitro, Melanoma, U266 - in-vivo, Melanoma, NA - in-vitro, Melanoma, RPMI-8226
Apoptosis↑, TumCCA↑, MMP↓, ROS↑, eff↓, NF-kB↓, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP1↑, MDA↑, SOD↓, SOD2↓, GCLM↓, GSTA1↓, FTH1↓, GSTs↓, TumVol↓,
2733- BetA,    Betulinic Acid Inhibits Cell Proliferation in Human Oral Squamous Cell Carcinoma via Modulating ROS-Regulated p53 Signaling
- in-vitro, Oral, KB - in-vivo, NA, NA
TumCP↓, TumVol↓, mt-Apoptosis↑, Casp3↑, Casp9↑, BAX↑, Bcl-2↑, OCR↓, TumCCA↑, ROS↑, eff↓, P53↑, STAT3↓, cycD1/CCND1↑,
2746- BetA,    Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo
- in-vitro, CRC, HCT116 - in-vivo, CRC, NA
TumCG↓, BAX↑, Bcl-2↓, ROS↑, MMP↓, TIMP2↑, TumVol↓,
9203- BITC,    Benzyl isothiocyanate inhibits tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in a BALB/c mouse xenograft model
- vitro+vivo, BC, 4T1
AntiTum↑, Dose↝, TumVol↓, TumW↓, PCNA↓, Bcl-2↓, CD31/PECAM-1↓, VEGF↓, BAX↑, cl‑Casp3↑, cl‑Casp7↑, cl‑Casp9↑, cl‑PARP↑, TumNum↓, TumMeta↓, MMP2↓, MMP9↓, TIMP1↓, uPA↓, TIMP2↑, PAI-1/SERPINE1↑,
5692- BJ,    Seed oil of Brucea javanica induces apoptosis through the PI3K/Akt signaling pathway in acute lymphocytic leukemia Jurkat cells
- vitro+vivo, AML, NA
Apoptosis↑, Akt↓, P53↑, FOXO1↑, GSK‐3β↑, TumVol↓, QoL↑, BBB↑, OS↑, Dose↝, MMP↓, ROS↑, XIAP↑, Casp9↑, Casp8↑, Casp3↑, cl‑PARP↑, TumCCA↑,
5683- BML,    Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway
- in-vitro, Melanoma, NA
COX2/PTGS2↓, MAPK↓, NF-kB↓, TumMeta↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, MAPK↓, ERK↓, Akt↓, TumVol↓,
5658- BNL,    Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage
- vitro+vivo, GBM, U251
ChemoSen↑, mt-Apoptosis↑, Casp↑, DNAdam↑, ROS↑, angioG↓, BBB↑, EPR↑, TumVol↓, TumW↓, BioEnh↑,
696- Bor,    Nothing Boring About Boron
- Review, Var, NA
*hs-CRP↓, *TNF-α↓, *SOD↑, *Catalase↑, *GPx↑, *cognitive↑, *memory↑, *Risk↓, *SAM-e↑, *NAD↝, *ATP↝, *Ca+2↝, HDAC↓, TumVol↓, IGF-1↓, PSA↓, Cyc↓, TumCMig↓, *serineP↓, HIF-1↓, *ChemoSideEff↓, *VitD↑, *Mag↑, *Synergy↑, Risk↓, *Inflam↓, *neuroP↑, *Calcium↑, *BMD↑, *chemoP↑, AntiCan↑, *Dose↑, *Dose↝, *BMPs↑, *testos↑, angioG↓, Apoptosis↑, *selectivity↑, *chemoPv↑,
746- Bor,    Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope
- Review, Var, NA
eff↑, *toxicity↓, ROS↑, LAT↓, AntiCan↑, AR↓, PSMB5↓, IGF-1↓, PSA↓, TumVol↓, eff↑, Rho↓, Cdc42↓, Ca+2↓, eff↑,
706- Bor,    Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice
- in-vivo, Pca, LNCaP
TumVol↓, IGF-1↓, PSA↓,
3518- Bor,    Boron Report
- Review, Var, NA - Review, AD, NA
Risk↓, serineP↓, PSA↓, TumVol↓, IGF-1↓, *Mag↑, *Calcium↑, *VitD↑, *COX2/PTGS2↓, *5LO↓, *PGE2↓, *NF-kB↓, *cognitive↑,
4624- Bor,  VitD3,    Boron as a Medicinal Ingredient in Oral Natural Health Products
- Review, Pca, NA
*Half-Life↝, *eff↑, PSA↓, TumVol↓, IGF-1↓, *memory↓, *motorD↓,
1169- Bos,    Boswellic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in Orthotopic Mouse Model By Downregulating Inflammatory, Proliferative, Invasive, and Angiogenic Biomarkers
- in-vivo, CRC, NA
TumCG↓, TumVol↓, Weight∅, ascitic↓, TumMeta↓, Ki-67↓, CD31/PECAM-1↓, NF-kB↓, COX2/PTGS2↓, Bcl-2↓, Bcl-xL↓, IAP1↓, survivin↓, cycD1/CCND1↓, ICAM-1↓, MMP9↓, CXCR4↓, VEGF↓,
8970- BRice,    Black rice diet alleviates colorectal cancer development through modulating tryptophan metabolism and activating AHR pathway
- Study, CRC, NA
Ingr↑, TumVol↓, OS↑, GutMicro↑, IBI↑, Risk↓, Ki-67↓, PCNA↓, AhR↑,
6555- BSB,    Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer
- vitro+vivo, PC, NA
TumCP↓, TumCI↓, p‑FAK↓, TumVol↓, Ki-67↓,

Showing Research Papers: 1 to 50 of 249
Page 1 of 5 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 249

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 3,   Catalase↓, 2,   Catalase↑, 2,   Fenton↑, 2,   GCLM↓, 1,   GPx↑, 1,   GPx1↓, 1,   GPx4↓, 4,   GSH↓, 7,   GSH↑, 1,   GSH/GSSG↓, 1,   GSTs↓, 1,   H2O2↑, 1,   HO-1↓, 2,   HO-1↑, 1,   hyperG↓, 1,   Iron↑, 4,   Iron∅, 1,   i-Iron↑, 1,   lipid-P↑, 4,   MDA↓, 1,   MDA↑, 4,   MPO↓, 1,   NQO1↑, 1,   NRF2↓, 2,   NRF2↑, 1,   NRF2↝, 1,   RNS↑, 1,   ROS↓, 4,   ROS↑, 59,   ROS↝, 1,   mt-ROS↑, 3,   SOD↓, 2,   SOD↑, 2,   SOD2↓, 2,   SOD2↑, 2,   TAC↓, 1,   TrxR1↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 2,   NCOA4↑, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC25↓, 3,   compI↓, 2,   ETC↓, 1,   HSP60/HSPD1↓, 2,   mitResp↓, 1,   mtDam↑, 3,   OCR↓, 2,   OCR↑, 2,   OXPHOS↑, 3,   mt-OXPHOS↑, 1,   PDH↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   ACC↑, 1,   ALAT↓, 3,   ALAT↑, 1,   ALDOAiso2↓, 1,   AMPK↓, 1,   AMPK↑, 2,   p‑AMPK↑, 2,   ATP↓, 3,   ATP↝, 1,   DHA↑, 1,   ECAR↓, 1,   ENO1↓, 1,   GAPDH↓, 1,   GlucoseCon↓, 4,   Glycolysis↓, 12,   Glycolysis↑, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   p‑GSK‐3β↓, 1,   p‑GSK‐3β↑, 2,   HK2↓, 7,   HMG-CoA↓, 1,   lactateProd↓, 7,   LDHA↓, 2,   lipoGen↓, 1,   NAD↓, 1,   PDK1 / PDPK1↓, 1,   PDKs↓, 1,   PFK↓, 1,   PFK1↓, 1,   PGK1↓, 1,   PKM2↓, 6,   PLA2↓, 1,   Pyrim↓, 1,   SCD1↓, 1,   SIRT1↓, 1,   SIRT1↑, 1,   TS↓, 1,   Warburg↓, 4,  

Cell Death(tgid=5) ⓘ

AIF↑, 1,   Apoptosis?, 1,   Apoptosis↓, 1,   Apoptosis↑, 84,   mt-Apoptosis↑, 2,   ASK1↑, 1,   BAD↓, 1,   Bak↑, 1,   BAX↑, 31,   Bax:Bcl2↑, 7,   Bcl-2↓, 44,   Bcl-2↑, 1,   Bcl-xL↓, 13,   BIM↑, 2,   Casp↑, 7,   proCasp↑, 1,   Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 1,   Casp3↑, 39,   cl‑Casp3↑, 17,   proCasp3↑, 1,   Casp7?, 1,   Casp7↑, 4,   cl‑Casp7↑, 2,   Casp8↑, 8,   cl‑Casp8↑, 4,   Casp9?, 1,   Casp9↑, 19,   cl‑Casp9↑, 5,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 11,   DR5↑, 1,   Endon↑, 1,   FasL↑, 2,   Ferroptosis↓, 1,   Ferroptosis↑, 6,   GSDMD↑, 1,   GSDME↑, 1,   IAP1↓, 2,   IAP2/BIRC3↓, 1,   ICD↑, 2,   iNOS↓, 2,   Mcl-1↓, 6,   MDM2↓, 2,   necrosis↑, 3,   p38↑, 2,   p‑p38↑, 4,   Pyro↑, 2,   survivin↓, 20,   TRAIL↑, 1,   TumCD↑, 13,   XIAP↓, 10,   XIAP↑, 1,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 28,   Akt↑, 3,   p‑Akt↓, 9,   AMPKα↓, 1,   AMPKα↑, 1,   BRAF↓, 1,   DYRK1B↓, 1,   EGFR↓, 3,   ERK↓, 6,   p‑ERK↓, 7,   p‑ERK↑, 1,   GNAI1↓, 1,   HER2/EBBR2↓, 1,   Hippo↓, 1,   IGF-1R↓, 3,   IKKα↓, 1,   IKKα↑, 1,   p‑IKKα↓, 2,   ILK↓, 1,   IR↓, 1,   IκB↓, 1,   IκB↑, 1,   JAK1↓, 2,   JAK2↓, 5,   JNK↓, 1,   JNK↑, 3,   p‑JNK↑, 3,   LIFR/CD118↓, 1,   MAPK↓, 6,   MAPK↑, 1,   MEK↓, 1,   mTOR↓, 14,   mTOR↑, 3,   p‑mTOR↓, 3,   p‑p70S6↓, 1,   P70S6K↓, 1,   PI3K↓, 23,   PI3K↑, 2,   p‑PI3K↓, 1,   p‑PI3k/Akt/mTOR↓, 1,   PIK3CA↑, 1,   PKA↓, 2,   PKCδ↓, 1,   PTEN↓, 1,   PTEN↑, 3,   Raf↓, 1,   SHP1↑, 1,   c-Src↓, 1,   STAT↓, 1,   STAT3↓, 19,   p‑STAT3↓, 3,   p‑STAT3↑, 2,   i-STAT3↓, 1,   STAT4↑, 1,   STAT5↓, 2,   TK1↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 1,   cMyc↓, 5,   DNMT1↓, 2,   DNMT3B↓, 1,   EZH2↓, 2,   FOXM1↓, 1,   FOXO1↑, 1,   FOXO3↑, 1,   ac‑H3↑, 2,   ac‑H4↑, 2,   HDAC↓, 7,   HDAC1↓, 2,   HDAC2↓, 3,   HDAC3↓, 3,   IRF1↑, 1,   KCNQ1OT1↓, 1,   KLF2↓, 1,   KLF4↓, 1,   KLF5↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-21↓, 1,   miR-224↓, 1,   miR-340↓, 1,   miR-34a↑, 1,   miR-375↑, 1,   miR-422a↑, 1,   miR-497↑, 1,   OCT4↓, 5,   other↓, 2,   other↝, 10,   SALL4↓, 1,   SD↑, 1,   SOX2↓, 2,   TFE3↑, 1,   tumCV↓, 32,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 2,   eIF2α↑, 1,   ER Stress↓, 1,   ER Stress↑, 3,   GRP78/BiP↑, 3,   HSP70/HSPA5↓, 3,   HSP70/HSPA5↑, 1,   HSP90↓, 3,   HTRA↓, 2,   PERK↑, 1,   Proteasome↓, 1,   PSMB5↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

APA↑, 1,   ATG5↑, 3,   ATG5↝, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 2,   Beclin-1/ATG6⇅, 1,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3A↑, 1,   LC3B↑, 1,   LC3B-II↓, 1,   LC3B-II↑, 1,   LC3I↑, 1,   LC3II↑, 1,   lysoMP↓, 1,   lysoMP↑, 1,   p62↓, 3,   p62↑, 2,   TumAuto↓, 2,   TumAuto↑, 17,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 13,   DNArepair↓, 1,   hTERT/TERT↓, 3,   NKX3.1↓, 1,   P53↑, 22,   i-P53↓, 1,   PARP↓, 1,   PARP↑, 2,   cl‑PARP↑, 21,   PARP1↑, 1,   cl‑PARP1↑, 3,   PCNA↓, 10,   PCNA↝, 1,   Telomerase↓, 1,   TOP2↓, 2,   γH2AX↑, 4,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 4,   CDK2↓, 6,   CDK4↓, 7,   CDK4↑, 2,   CDK6↓, 1,   CDK6↑, 3,   CDKN1C/p57↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 4,   CycB/CCNB1↓, 6,   cycD1/CCND1↓, 24,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 3,   cycE1↓, 1,   E2Fs↓, 2,   FBXO5/EMI1↓, 1,   Ki-67↓, 23,   mitA↓, 1,   mitA↑, 2,   P21↓, 2,   P21↑, 15,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 4,   TubPol↓, 1,   TumCCA↑, 54,   UBE2C↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   ALDH↓, 4,   AXIN1↑, 1,   CD133↓, 2,   CD24↓, 1,   CSCs↓, 11,   CSCsMark↓, 1,   Diff↑, 1,   EP2↓, 1,   FGF↓, 2,   Gli1↓, 3,   HH↓, 4,   HH∅, 1,   IGF-1↓, 6,   Ki-67↓, 23,   LGR5↓, 1,   LRP6↓, 1,   p‑LRP6↓, 1,   mTORC1↓, 2,   Nanog↓, 2,   NOTCH↓, 1,   NOTCH1↓, 2,   NOTCH3↓, 1,   PTCH2↓, 1,   SCF↓, 1,   Shh↓, 3,   Smo↓, 1,   TumCG?, 1,   TumCG↓, 38,   TumCP↓, 59,   TumCP↑, 1,   WDR72↓, 1,   Wnt↓, 6,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

ANGPT2↓, 1,   AP-1↓, 2,   Ca+2↓, 1,   Ca+2↑, 9,   Ca+2↝, 1,   CAFs/TAFs↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   COL1↓, 1,   E-cadherin↑, 10,   EMT↓, 17,   EpCAM↓, 2,   F-actin↓, 1,   p‑FAK↓, 1,   GLI3↓, 1,   hnRNPA1↓, 1,   ITGB4↓, 1,   MALAT1↓, 1,   MMP1↓, 1,   MMP16↓, 1,   MMP2↓, 15,   MMP3↓, 2,   MMP7↓, 2,   MMP9↓, 20,   MMPs↓, 3,   MUC1-C↓, 1,   MUC4↓, 1,   N-cadherin↓, 7,   PAI-1/SERPINE1↑, 1,   PAK1↑, 1,   Rho↓, 1,   serineP↓, 1,   Slug↓, 2,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   Snail↓, 4,   TGF-β↓, 3,   TGF-β↑, 1,   TIMP1↓, 1,   TIMP1↑, 2,   TIMP2↑, 5,   TumCI↓, 26,   TumCMig↓, 38,   TumMeta?, 1,   TumMeta↓, 28,   Twist↓, 2,   uPA↓, 2,   Vim↓, 5,   Zeb1↓, 1,   α-SMA↓, 1,   α-SMA↑, 1,   β-catenin/ZEB1↓, 8,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 28,   CD31/PECAM-1↓, 3,   Endoglin↓, 1,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 14,   NO↓, 1,   NO↑, 1,   VCAM-1↓, 2,   VEGF↓, 22,   VEGF↑, 1,   VEGFR2/KDR/Flk1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 3,   CellMemb↑, 1,   CLDN1↓, 1,   EPR↓, 1,   EPR↑, 4,   GLUT1↓, 3,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT4↓, 1,   IBI↑, 1,   LAT↓, 1,   MMP↓, 23,   MMP↑, 1,   MPT↑, 1,   SLC12A5↓, 1,   SVCT-2↝, 1,   TRPM7↓, 1,   VGSC↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 5,   CD47↓, 1,   CD8+↑, 3,   COX2/PTGS2↓, 16,   COX2/PTGS2↑, 1,   CXCR4↓, 2,   Gal-3↓, 1,   GM-CSF↓, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 2,   IL1↑, 1,   IL10↓, 1,   IL18↓, 1,   IL1β↓, 8,   IL1β↑, 1,   IL4↓, 2,   IL6↓, 12,   IL7↓, 1,   IL8↓, 3,   Imm↑, 4,   Imm↝, 2,   Inflam↓, 4,   Macrophages↓, 1,   Neut↓, 1,   NF-kB↓, 31,   NF-kB↑, 1,   NK cell↑, 3,   NLRP3↑, 1,   p65↓, 4,   p‑p65↓, 3,   PD-L1↓, 1,   PD-L1↑, 2,   PGE1↓, 1,   PGE2↓, 2,   PSA↓, 8,   RANTES↓, 1,   SOCS1↑, 1,   T-Cell↑, 1,   TCF↝, 1,   TLR4↓, 1,   TNF-α↓, 8,   TNF-α↑, 2,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,   pH↑, 1,   pH∅, 1,   e-pH↓, 1,   e-pH↑, 1,   i-pH↓, 1,   Temp∅, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

ChE↓, 1,   SYN1↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↑, 1,   AR↓, 5,   AR-FL↓, 1,   AR-V7↑, 1,   CYP19↓, 1,   ER(estro)↓, 1,   Estro↝, 1,   FKBP5↓, 1,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 9,   BioAv↑, 8,   BioAv↝, 4,   BioEnh↑, 2,   ChemoSen?, 2,   ChemoSen↑, 37,   ChemoSen⇅, 1,   CompStab↓, 1,   Dose?, 3,   Dose↓, 1,   Dose↑, 2,   Dose↝, 66,   Dose∅, 5,   eff↓, 27,   eff↑, 39,   eff↝, 6,   eff∅, 3,   GSTA1↓, 1,   GSTZ1↓, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 2,   MDR1↓, 1,   P-gp/ABCB1↓, 2,   RadioS?, 1,   RadioS↑, 5,   RadioS↝, 1,   selectivity↑, 39,   Synergy↑, 29,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 3,   ALAT↓, 3,   ALAT↑, 1,   ALB↑, 1,   ALP↑, 1,   AR↓, 5,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 1,   BRAF↓, 1,   BUN↓, 1,   CA125↓, 1,   CEA↓, 1,   CYFRA21-1↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 3,   EZH2↓, 2,   FOXM1↓, 1,   HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6↓, 12,   IRes↓, 1,   LDH↓, 1,   LDH↑, 2,   PD-L1↓, 1,   PD-L1↑, 2,   PSA↓, 8,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 15,   antiNeop↑, 1,   AntiTum↑, 9,   cardioP↑, 4,   chemoP↑, 12,   chemoPv↑, 4,   cognitive↑, 1,   fatigue↓, 2,   hepatoP↑, 4,   motorD↑, 1,   Mucositis↓, 1,   neuroP↑, 2,   NP/CIPN↓, 1,   OS↑, 33,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 9,   radioP↑, 7,   Remission↑, 3,   Risk↓, 8,   Sleep↑, 1,   toxicity↓, 20,   toxicity↝, 2,   toxicity∅, 1,   TumNum↓, 2,   TumVol?, 1,   TumVol↓, 244,   TumVol↑, 3,   TumVol⇅, 1,   TumVol∅, 1,   TumW↓, 60,   TumW⇅, 1,   TumW∅, 1,   Weight↓, 2,   Weight↑, 7,   Weight∅, 3,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,   GutMicro↑, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 3,  
Total Targets: 605

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 10,   Catalase↑, 8,   Fenton↓, 1,   GPx↑, 4,   GPx1↑, 1,   GSH↑, 2,   GSR↑, 1,   GSTs↑, 3,   HDL↑, 1,   HO-1↑, 3,   lipid-P↓, 4,   MDA↓, 4,   MPO↓, 2,   NOX↓, 1,   NOX4↓, 1,   NRF2↑, 4,   RNS↓, 1,   ROS↓, 14,   ROS∅, 1,   SAM-e↑, 1,   SOD↑, 6,   SOD1↑, 1,   TAC↑, 1,   TBARS↓, 1,   VitE↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   adiP↑, 1,   ALAT↓, 2,   ATP↑, 1,   ATP↝, 1,   FASN↓, 1,   glucose↓, 1,   LDL↓, 1,   NAD↝, 1,   NADPH↓, 1,   NH3↓, 1,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 2,   Bcl-2↑, 1,   Bcl-xL↑, 1,   Casp12↓, 1,   Casp3↓, 3,   Casp8↓, 1,   Casp9↓, 2,   GranB/GZMB↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 2,   CREB↑, 1,   ERK↓, 1,   IκB↓, 1,   JAK2↑, 1,   p‑JNK↓, 1,   MAPK↓, 2,   mTOR↓, 1,   PI3K↑, 2,   PTEN↑, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 2,   HDAC↓, 1,   other↑, 1,   tumCV↓, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   PERK↓, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   IGF-1↓, 1,   TumCP↓, 1,  

Migration(tgid=13) ⓘ

Ca+2↝, 1,   serineP↓, 1,   TGF-β↑, 1,   TumCI↓, 1,   TumCMig↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

Endoglin↑, 1,   p‑eNOS↑, 1,   Hif1a↑, 1,   NO↓, 2,   VEGF↑, 2,  

Barriers & Transport(tgid=15) ⓘ

IBI↑, 1,   MMP↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   COX2/PTGS2↓, 3,   FOXP3↑, 1,   HMGB1↓, 1,   IFN-γ↓, 1,   IL10↓, 1,   IL10↑, 2,   IL1β↓, 2,   IL4↓, 1,   IL4↑, 1,   IL6↓, 5,   Imm↑, 1,   Inflam↓, 12,   LPS↓, 1,   M2 MC↑, 1,   MCP1/CCL2↓, 1,   NF-kB↓, 6,   NLRP3↓, 2,   PGE2↓, 2,   TNF-α↓, 6,   Treg lymp↝, 1,   VitD↑, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↑, 2,   PSD95↑, 1,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 1,   Aβ↓, 2,   BACE/β-secretase↓, 1,   β-Amyloid↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

END↑, 1,   FGF21↑, 1,   testos↑, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   BioAv↑, 7,   BioAv↝, 3,   Dose↓, 1,   Dose↑, 2,   Dose↝, 5,   eff↑, 5,   Half-Life↝, 2,   P450↓, 1,   selectivity↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AST↓, 2,   BMD↑, 1,   Calcium↑, 2,   CEA↓, 2,   creat↓, 2,   hs-CRP↓, 1,   IL6↓, 5,   LDH↓, 1,   Mag↑, 2,   SpO2↑, 1,   TC↓, 1,   Urea↓, 1,   VitD↑, 2,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 2,   AntiCan↑, 2,   AntiDiabetic↑, 1,   antiPs↑, 1,   cardioP↑, 5,   chemoP↑, 1,   chemoPv↑, 1,   ChemoSideEff↓, 1,   cognitive↑, 5,   hepatoP↑, 2,   memory↓, 1,   memory↑, 3,   motorD↓, 1,   neuroP↑, 9,   Obesity↓, 3,   OS↑, 2,   RenoP↑, 2,   Risk↓, 1,   Stroke↓, 2,   toxicity↓, 12,   toxicity↝, 4,   toxicity∅, 7,   Weight↑, 1,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↓, 1,   AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 3,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,  
Total Targets: 180

Scientific Paper Hit Count for: TumVol, Tumor Volume
16 Magnetic Fields
9 Silver-NanoParticles
9 doxorubicin
9 Magnetic Field Rotating
8 Curcumin
7 Quercetin
6 Hydrogen Gas
5 Apigenin (mainly Parsley)
5 Boron
5 EGCG (Epigallocatechin Gallate)
4 itraconazole
4 immunotherapy
4 Melatonin
4 Shikonin
4 Thymoquinone
3 Photodynamic Therapy
3 Vitamin C (Ascorbic Acid)
3 Ashwagandha(Withaferin A)
3 Betulinic acid
3 Radiotherapy/Radiation
3 Cisplatin
3 Dichloroacetate
3 5-fluorouracil
3 Evodiamine
3 Fenbendazole
3 Ginkgetin
3 Inositol
3 Ivermectin
3 mebendazole
3 MCT, metronomic chemo
3 Silymarin (Milk Thistle) silibinin
2 cetuximab
2 EMF
2 Gold NanoParticles
2 Allyl isothiocyanate
2 Allicin (mainly Garlic)
2 Baicalein
2 Berbamine
2 Berberine
2 Beta-Caryophyllene
2 Caffeic acid
2 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
2 Centella asiatica / Gotu kola → asiaticoside
2 Chlorogenic acid
2 Chrysin
2 Chemotherapy
2 Eugenol
2 Fisetin
2 Formononetin
2 Flaxseed Oil
2 Gallic acid
2 Orlistat
2 Hibiscus sabdariffa
2 Honokiol
2 Hyperoside
2 Sulforaphane (mainly Broccoli)
2 Juglone
2 Kaempferol
2 L-Theanine
2 Licochalcone A
2 SDG/lignans
2 Luteolin
2 capecitabine
2 Mangiferin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Naringin
2 Terpinen-4-ol / Tea Tree Oil
2 Aflavin-3,3′-digallate
1 1,8-Cineole
1 3-bromopyruvate
1 Açaí, Euterpe oleracea
1 chemodynamic therapy
1 wortmannin
1 Ajoene (compound of Garlic)
1 Alpha-Lipoic-Acid
1 low dose naltrexone
1 Artemisinin
1 Benzyl isothiocyanate
1 Brucea javanica
1 Bromelain
1 borneol
1 Vitamin D3
1 Boswellia (frankincense)
1 Black Rice, Oryza sativa
1 α-Bisabolol / Chamomile oil
1 Caffeine
1 Zinc
1 Capsaicin
1 Carvacrol
1 Cannabidiol
1 Celastrol
1 chaetocin
1 chitosan
1 Cucurbitacin
1 Oxaliplatin
1 Chlorella (Chlorella vulgaris)
1 SonoDynamic Therapy UltraSound
1 Cynaropicrin
1 Metformin
1 Bortezomib
1 Deguelin
1 diet FMD Fasting Mimicking Diet
1 diet Methionine-Restricted Diet
1 Diindolylmethane
1 Dandelion Root
1 Ginkgo biloba-EGb 761
1 Docetaxel
1 Emodin
1 Tetrahydroxystilbene glucoside
1 Electrical Pulses
1 Ferulic acid
1 Paclitaxel/Taxol
1 Flaxseed/Linseed
1 Fucoidan
1 Garcinol
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 Graviola
1 HydroxyCitric Acid
1 Hyperthermia
1 Indole-3-carbinol
1 iodine
1 phytic acid, Inositol hexakisphosphate
1 Isothiocyanates
1 Isovitexin
1 Lasiodin
1 Licorice
1 Lemongrass Extract/Citral
1 Lycopene
1 Magnolol
1 Matrine
1 Modified Citrus Pectin
1 methylseleninic acid
1 Lemon Balm/Melissa officinalis
1 Morin
1 tamoxifen
1 Mistletoe/Viscum album Extracts
1 Helleborus niger extracts – Christmas Rose
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Bicarbonate(Sodium)
1 Patchouli Oil (Pogostemon cablin)
1 Phenylbutyrate
1 Phycocyanin
1 Piperine
1 probiotics
1 Pterostilbene
1 enzalutamide
1 Resveratrol
1 Rutin
1 salinomycin
1 α-Santalol/Sandalwood oil
1 Selenium
1 Oxygen, Hyperbaric
1 Sesamin
1 Iron
1 Salvia miltiorrhiza
1 Thymol-Thymus vulgaris
1 Magnesium
1 Vitamin K2
1 Walnut
1 Xylitol
1 Zerumbone
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:530  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page